Model: | Ratio |
Symbol | Title | Sector | Industry | M.Cap.[M] | Div Yield | Last Close | AvgVol 200d |
NVS | Novartis AG ADR | Healthcare | Drug Manufacturers - General | 242663 | 0.033 | 122.12 | 1668292 |
GSK | GlaxoSmithKline PLC ADR | Healthcare | Drug Manufacturers - General | 77652 | 0.0417 | 38.19 | 5324260 |
Entry Threshold: | 2.00 | Exit Threshold: | 0.00 | ||
Max Duration: | 20 | Entry Mode: | Uptick | Reversals: | |
MA Period: | 15 | MA Type: | EMA | StdDev Period: | 15 |
RSI Period: | 14 | RSI Threshold: | 0 | ||
Margin Req. 1: | 50.0 | Margin Req. 2: | 50.0 | ||
Version: | 5 | Model Version: | 2016.1 | Bid-Ask 0.01 / 0.01 |
Initial Capital: | 10000.00 | Final Equity: | 7509.97 |
Total net P/L: | -2490.03 | Total ROI: | -24.90 % |
CAGR: | -5.08 % | Max. DD: | 37.72 % |
System Score: | -1.709 | Sharpe Ratio: | -0.619 |
Start Date: | 2020-01-02 | End Date: | 2025-06-30 |
Total days: | 2006 | ||
Commissions: | 346.87 | Comm.% P/L | 16.18 % |
Total Transactions: | 336 | Log. Linearity: | 69.557 % |
Total | ![]() |
![]() |
NVS | GSK | |
---|---|---|---|---|---|
Total Profit/Loss | -2143.16 | 362.31 | -2505.47 | -3324.67 | 1181.51 |
Total Profit | 9227.39 | 4634.91 | 4592.48 | 7993.71 | 12338.10 |
Total Loss | 11370.55 | 4272.60 | 7097.95 | 11318.38 | 11156.59 |
Profit Factor | 0.81 | 1.08 | 0.65 | 0.71 | 1.11 |
Trades | 84 | 40 | 44 | 84 | 84 |
Winning Trades | 50 | 25 | 25 | 42 | 50 |
Losing Trades | 34 | 15 | 19 | 42 | 34 |
% Profitable | 59.00 | 62.00 | 56.00 | 50.00 | 59.00 |
Profit/Loss Per Trade % | -0.29 | 0.15 | -0.69 | -0.52 | 0.14 |
Profit Per Trade % | 2.36 | 2.38 | 2.33 | 2.35 | 3.06 |
Loss Per Trade % | 3.94 | 3.39 | 4.38 | 3.24 | 3.88 |
Days In Trade | 1127 | 526 | 601 | 1127 | 1127 |
Days In Trade (Avg. Per Trade) | 13.42 | 13.15 | 13.66 | 13.42 | 13.42 |
% Days In Trade | 56.18 | 26.22 | 29.96 | 56.18 | 56.18 |